Natural Progression of Helicobacter pylori-Negative Gastritis with Lymphoid Follicles in Children: Prospective

Vered Richter1, Sonia Mendlovic2, Tzipi Shalem3

  • 1The Gonczarowski Family Institute of Gastroenterology and Liver Disease, Shamir Medical Center, Zerifin, Israel.

Insights

In children with Helicobacter pylori-negative gastritis, lymphoid follicles (LFs) often persist even after gastritis resolves. These findings suggest LFs may be a non-pathological feature in pediatric gastritis, not requiring further follow-up.

Area of Science:

  • Pediatric Gastroenterology
  • Histopathology
  • Microbiome Research

Background:

  • The significance of lymphoid follicles (LFs) in pediatric H. pylori-negative gastritis remains unclear.
  • Understanding the natural history of this condition is crucial for appropriate clinical management.

Purpose of the Study:

  • To investigate the natural history and clinical significance of H. pylori-negative gastritis with LFs in children.
  • To determine if LFs in pediatric gastritis represent a pathological finding requiring intervention.

Main Methods:

  • Retrospective identification of pediatric patients with H. pylori-negative gastritis and LFs.
  • Follow-up esophagogastroduodenoscopy (EGD) and histological review.
  • Comparison of initial and follow-up clinical, endoscopic, and histological findings.

Main Results:

  • Of 48 children with H. pylori-negative gastritis, 17 (35.41%) had LFs.
  • In a subset of 8 children followed for a mean of 25.58 months, LFs persisted in 3 despite chronic gastritis.
  • Four children showed gastritis resolution but retained LFs; one resolved both.
  • One patient had resolution of both gastritis and LFs.

Conclusions:

  • Lymphoid follicles (LFs) can persist in children with H. pylori-negative gastritis for up to two years.
  • LFs may remain present even after the resolution of gastritis.
  • This histological finding is likely a non-pathological feature in children and may not necessitate further follow-up or intervention.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
646
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
241
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
615
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
716
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
340
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
177